Related Experiment Video
Updated: Apr 25, 2026
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Circulating sclerostin associated with vertebral bone marrow fat in older men but not women
Yu-Heng Vivian Ma1, Ann V Schwartz, Sigurdur Sigurdsson
1University of California, San Francisco (Y.-H.V.M., A.V.S., T.F.H., T.F.L., E.V., L.P., X.L.), San Francisco, California 94107; Icelandic Heart Association (S.S., G.E., A.M.H., K.S., D.O., V.G.), IS-201 Kopavogur, Iceland; Laboratory of Epidemiology, Demography, and Biometry (T.B.H.), Intramural Research Program, National Institute on Aging, Bethesda, Maryland 20892; Maine Medical Center Research Institute (C.J.R.), Scarborough, Maine 04074; Faculty of Medicine (G.S., D.O., V.G.), University of Iceland, IS-101 Reykjavik, Iceland; Department of Endocrinology and Metabolism (G.S.), Landspitali University Hospital, IS-101 Reykjavik, Iceland; and Universita Campus Bio-Medico (N.N.), 00128 Rome, Italy.
Context:
Osteocyte activity is crucial to the maintenance of bone quality. Sclerostin, an osteocyte product, inhibits bone formation, yet higher circulating sclerostin is associated with higher bone density. Bone marrow fat (MF) is associated with osteoporosis, but little is known about the relationship between osteocyte activity and MF.
Objective:
Our objective was to assess the relationships between circulating sclerostin, vertebral MF, volumetric bone mineral density (vBMD), and other fat depots in older adults.
Design, Setting, And Participants:
We conducted a cross-sectional study in the Age Gene/Environment Susceptibility-Reykjavik cohort.
Main Outcome Measures:
Outcome measures included vertebral MF (L1-L4) measured with magnetic resonance spectroscopy and vBMD (spine and hip) and abdominal fat measured with quantitative computed tomography.
Results:
After excluding subjects with bone-active medication use (n = 50), inadequate serum (n = 2), or inadequate magnetic resonance spectroscopy (n = 1), analyses included 115 men and 134 women (mean age 79 y, mean body mass index 27.7 kg/m(2)). In men, but not women, vertebral MF was greater in those with higher serum sclerostin levels. MF was 52.2 % in the lowest tertile of serum sclerostin and 56.3% in the highest tertile in men (P for trend <.01) in models adjusted for age, body mass index, and diabetes. Sclerostin was positively associated with cortical and trabecular total hip vBMD, weight in men and women, and total fat mass in men but was not associated with total lean mass or abdominal fat depots.
Conclusion:
Circulating sclerostin levels are associated with higher vertebral marrow fat in men, suggesting a relationship between osteocyte function and marrow adipogenesis.
More Related Videos
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
Related Concept Videos
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:40Bone Remodeling
01:31Osteoclasts in Bone Remodeling
01:23Cirrhosis I: Introduction
01:21Skeleton and Calcium Homeostasis
01:09Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...